Actively Recruiting
Transpacific TAVR Registry
Led by Duk-Woo Park, MD · Updated on 2026-01-02
10000
Participants Needed
7
Research Sites
915 weeks
Total Duration
On this page
Sponsors
D
Duk-Woo Park, MD
Lead Sponsor
C
CardioVascular Research Foundation, Korea
Collaborating Sponsor
AI-Summary
What this Trial Is About
This registry evaluates the long-term outcome of Transcatheter aortic valve replacement (TAVR) in real-world clinical practice.
CONDITIONS
Official Title
Transpacific TAVR Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- All patients undergoing transcatheter aortic valve replacement (TAVR)
- Informed consent
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 7 locations
1
Stanford University
Stanford, California, United States, 94305
Actively Recruiting
2
Northwestern Memorial Hospital
Chicago, Illinois, United States, 60611
Actively Recruiting
3
Second Affiliated Hospital of Zhejiang University
Hangzhou, China
Actively Recruiting
4
Bucheon Sejong Hospital
Bucheon-si, South Korea
Active, Not Recruiting
5
Chungnam National University Hospital
Daejeon, South Korea
Actively Recruiting
6
Asan Medical Center
Seoul, South Korea
Actively Recruiting
7
Seoul National University Hospital
Seoul, South Korea
Completed
Research Team
D
Duk-woo Park, MD
CONTACT
D
Do-yoon Kang, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here